Interleukin-4 and Interleukin-10 Are Chondroprotective and Decrease Mononuclear Cell Recruitment in Human Rheumatoid Synovium in Vivo

Overview

Journal Immunology

Specialty Allergy & Immunology

Date 1998 Jul 11

PMID 9659224

Citations 16

Authors

C Jorgensen

F Apparailly

I Couret

F Canovas

C Jacquet

J Sany

Affiliations

Soon will be listed here.

Abstract

We used the severe combined immunodeficient (SCID) mouse model to assess the effect of interleukin-4 (IL-4) or IL-10 injection on cartilage degradation and mononuclear cell (MNC) recruitment to human rheumatoid synovium in vivo. Human rheumatoid synovium and cartilage from five rheumatoid arthritis patients, obtained after joint replacement surgery, were engrafted subcutaneously to 6-8-week-old SCID CB17 mice. Synovial tissues were injected with recombinant human IL-4 (rhIL-4, 100 ng; rhIL-10, 100 ng), both cytokines, or tumour necrosis factor-alpha (TNF-alpha) (1000 U), or phosphate-buffered saline twice a week for 4 weeks. The graft was removed and immunochemical analysis was carried out to assess intracellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin expression. Moreover, cartilage degradation was assessed through the quantification of the erosion surface on a computerized image of the engrafted cartilage at high power view. MNC recruitment in the synovial tissue was determined by labelling blood MNC with indium-111 before their intraperitoneal injection. The activity obtained in the region of the graft were determined with a gamma camera 72 hr postinjection. The results are expressed as a percentage of initial injected activity. After 4 weeks we observed a decrease of cartilage area in controls (77 +/- 8%), inhibited after injection of IL-4, IL-10, or both cytokines (90 +/- 3%, 89.1 +/- 4%, 89.2 +/- 5% respectively), and 57 +/- 17% after TNF-alpha injection. The % MNC activity in the graft decreased to 77 +/- 81% (NS), 9 +/- 4% (P < 0.003) and 19 +/- 6% (P < 0.007) compared with untreated synovial tissue after treatment with IL-4, IL-10, or both cytokines, respectively. Moreover, IL-10 but not IL-4 decreased the expression of ICAM-1 but not VCAM-1 or E-selectin by synovial cells. These results suggest that IL-10 and IL-4 could have chondroprotective properties, and that IL-10 but not IL-4 inhibits MNC traffic towards the synovial tissue efficiently.

Citing Articles

Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis.

Iwaszko M, Bialy S, Bogunia-Kubik K Cells. 2021; 10(11).

PMID: 34831223 PMC: 8616130. DOI: 10.3390/cells10113000.

Gender Differences in Rheumatoid Arthritis: Interleukin-4 Plays an Important Role.

Yu C, Liu C, Jiang J, Li H, Chen J, Chen T J Immunol Res. 2021; 2020:4121524.

PMID: 33426089 PMC: 7781692. DOI: 10.1155/2020/4121524.

Humanized Mouse Models of Rheumatoid Arthritis for Studies on Immunopathogenesis and Preclinical Testing of Cell-Based Therapies.

Schinnerling K, Rosas C, Soto L, Thomas R, Aguillon J Front Immunol. 2019; 10:203.

PMID: 30837986 PMC: 6389733. DOI: 10.3389/fimmu.2019.00203.

Extracellular and intracellular mechanisms of mechanotransduction in three-dimensionally embedded rat chondrocytes.

Shioji S, Imai S, Ando K, Kumagai K, Matsusue Y PLoS One. 2014; 9(12):e114327.

PMID: 25479057 PMC: 4257595. DOI: 10.1371/journal.pone.0114327.

Imaging evaluation of inflammation in the musculoskeletal system: current concepts and perspectives.

Bierry G, Dietemann J Skeletal Radiol. 2013; 42(10):1347-59.

PMID: 23685709 DOI: 10.1007/s00256-013-1636-1.

References

Arnett F, Edworthy S, Bloch D, McShane D, Fries J, Cooper N . The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31(3):315-24. DOI: 10.1002/art.1780310302. View

Maini R, Elliott M, Brennan F, Williams R, Chu C, Paleolog E . Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease. Immunol Rev. 1995; 144:195-223. DOI: 10.1111/j.1600-065x.1995.tb00070.x. View

de Waal Malefyt R, Abrams J, Bennett B, Figdor C, De Vries J . Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991; 174(5):1209-20. PMC: 2119001. DOI: 10.1084/jem.174.5.1209. View

Iigo Y, Takashi T, Tamatani T, Miyasaka M, Higashida T, Yagita H . ICAM-1-dependent pathway is critically involved in the pathogenesis of adjuvant arthritis in rats. J Immunol. 1991; 147(12):4167-71. View

Vannier E, Miller L, Dinarello C . Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci U S A. 1992; 89(9):4076-80. PMC: 525635. DOI: 10.1073/pnas.89.9.4076. View

Johnson B, Haines G, Harlow L, Koch A . Adhesion molecule expression in human synovial tissue. Arthritis Rheum. 1993; 36(2):137-46. DOI: 10.1002/art.1780360203. View

Cronstein B, Weissmann G . The adhesion molecules of inflammation. Arthritis Rheum. 1993; 36(2):147-57. DOI: 10.1002/art.1780360204. View

Issekutz A, Issekutz T . Quantitation and kinetics of blood monocyte migration to acute inflammatory reactions, and IL-1 alpha, tumor necrosis factor-alpha, and IFN-gamma. J Immunol. 1993; 151(4):2105-15. View

Rendt K, Barry T, Jones D, Richter C, McCachren S, Haynes B . Engraftment of human synovium into severe combined immune deficient mice. Migration of human peripheral blood T cells to engrafted human synovium and to mouse lymph nodes. J Immunol. 1993; 151(12):7324-36. View

10.

Sack U, Kuhn H, Ermann J, Kinne R, Vogt S, JUNGMICHEL D . Synovial tissue implants from patients with rheumatoid arthritis cause cartilage destruction in knee joints of SCID.bg mice. J Rheumatol. 1994; 21(1):10-6. View

11.

Katsikis P, Chu C, Brennan F, Maini R, Feldmann M . Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med. 1994; 179(5):1517-27. PMC: 2191503. DOI: 10.1084/jem.179.5.1517. View

12.

Simon A, Seipelt E, Sieper J . Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci U S A. 1994; 91(18):8562-6. PMC: 44646. DOI: 10.1073/pnas.91.18.8562. View

13.

Geiler T, Kriegsmann J, Keyszer G, Gay R, Gay S . A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice. Arthritis Rheum. 1994; 37(11):1664-71. DOI: 10.1002/art.1780371116. View

14.

Iademarco M, Barks J, Dean D . Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells. J Clin Invest. 1995; 95(1):264-71. PMC: 295423. DOI: 10.1172/JCI117650. View

15.

Issekutz A, Issekutz T . Monocyte migration to arthritis in the rat utilizes both CD11/CD18 and very late activation antigen 4 integrin mechanisms. J Exp Med. 1995; 181(3):1197-203. PMC: 2191943. DOI: 10.1084/jem.181.3.1197. View

16.

Cohen S, Katsikis P, Chu C, Thomssen H, Webb L, Maini R . High level of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane. Arthritis Rheum. 1995; 38(7):946-52. DOI: 10.1002/art.1780380710. View

17.

Lacraz S, Nicod L, Chicheportiche R, Welgus H, Dayer J . IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest. 1995; 96(5):2304-10. PMC: 185881. DOI: 10.1172/JCI118286. View

18.

van Roon J, van Roy J, Duits A, Lafeber F, Bijlsma J . Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4. Ann Rheum Dis. 1995; 54(10):836-40. PMC: 1010020. DOI: 10.1136/ard.54.10.836. View

19.

Sugiyama E, Kuroda A, Taki H, Ikemoto M, Hori T, Yamashita N . Interleukin 10 cooperates with interleukin 4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cells. J Rheumatol. 1995; 22(11):2020-6. View

20.

Stearns M, Wang M, Stearns M . IL-10 blocks collagen IV invasion by "invasion stimulating factor" activated PC-3 ML cells: upregulation of TIMP-1 expression. Oncol Res. 1995; 7(3-4):157-63. View